Italy’s Frugal Pharma Billionaire Eyes Place Among Global Leaders in Drug Injection Devices
- Stevanato says weight-loss drugs can vault group into top five
- Family company has longtime commitment to keeping debt down
This article is for subscribers only.
If you got a Covid or flu shot this winter, the vaccine may well have come out of a vial made by Stevanato Group SpA, one of just a handful of Italian firms listed on the New York Stock Exchange.
All it took to get there was “a 30-year startup phase,” said Franco Stevanato, the company’s frugal, self-effacing executive chairman, who opens the door himself to greet reporters visiting Stevanato Group’s offices in Milan.